Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options

Tekijä Jiang, Hanfang, Rugo, Hope S.
Julkaisussa Ther Adv Med Oncol (2015)

Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer

Tekijä Chien, A. Jo, Rugo, Hope S.
Julkaistu 2012

An Overview of PARP Inhibitors for the Treatment of Breast Cancer

Tekijä Cortesi, Laura, Rugo, Hope S., Jackisch, Christian
Julkaisussa Target Oncol (2021)

Amelioration of sexual adverse effects in the early breast cancer patient

Tekijä Melisko, Michelle E., Goldman, Mindy, Rugo, Hope S.
Julkaistu 2010

Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis

Tekijä Rugo, Hope S., Melin, Susan A., Voigt, Jeff
Julkaisussa Breast Cancer Res Treat (2017)

Androgen receptor gene expression in primary breast cancer

Tekijä Vidula, Neelima, Yau, Christina, Wolf, Denise, Rugo, Hope S.
Julkaisussa NPJ Breast Cancer (2019)

The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting

Tekijä Palli, Swetha Rao, Grabner, Michael, Quimbo, Ralph A, Rugo, Hope S
Julkaisussa Cancer Manag Res (2015)

Immune microenvironments in solid tumors: new targets for therapy

Tekijä Shiao, Stephen L., Ganesan, A. Preethi, Rugo, Hope S., Coussens, Lisa M.
Julkaistu 2011

Receptor Activator of Nuclear Factor Kappa B (RANK) Expression in Primary Breast Cancer Correlates with Recurrence Free Survival and Development of Bone Metastases in I-SPY1 (CALGB...

Tekijä Vidula, Neelima, Yau, Christina, Li, Jiali, Esserman, Laura J., Rugo, Hope S.
Julkaisussa Breast Cancer Res Treat (2017)

A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting

Tekijä Hesketh, Paul J., Aapro, Matti, Jordan, Karin, Schwartzberg, Lee, Bosnjak, Snezana, Rugo, Hope
Julkaisussa Biomed Res Int (2015)

Dual HER2 Blockade

Tekijä Thomssen, Christoph, El Saghir, Nagi S., Francis, Prudence A., Jassem, Jacek, Rugo, Hope S., Untch, Michael
Julkaisussa Breast Care (Basel) (2017)

Leukocyte composition of human breast cancer

Tekijä Ruffell, Brian, Au, Alfred, Rugo, Hope S., Esserman, Laura J., Hwang, E. Shelley, Coussens, Lisa M.
Julkaistu 2012

A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel

Tekijä Piawah, Sorbarikor, Hyland, Colby, Umetsu, Sarah E., Esserman, Laura J., Rugo, Hope S., Chien, A. Jo
Julkaisussa NPJ Breast Cancer (2019)

Clinical and biomarker predictors of side effects from tamoxifen

Tekijä Lorizio, Wendy, Wu, Alan H.B, Beattie, Mary S., Rugo, Hope, Tchu, Simone, Kerlikowske, Karla, Ziv, Elad
Julkaistu 2011

The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea

Tekijä Rugo, Hope S., Di Palma, Jack A., Tripathy, Debu, Bryce, Richard, Moran, Susan, Olek, Elizabeth, Bosserman, Linda
Julkaisussa Breast Cancer Res Treat (2019)

Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes

Tekijä Uno, Hajime, Schrag, Deborah, Kim, Dae Hyun, Tang, Dejun, Tian, Lu, Rugo, Hope S, Wei, Lee-Jen
Julkaisussa JNCI Cancer Spectr (2019)

Understanding the Role of Comparative Clinical Studies in the Development of Oncology Biosimilars

Tekijä Stebbing, Justin, Mainwaring, Paul N., Curigliano, Giuseppe, Pegram, Mark, Latymer, Mark, Bair, Angel H., Rugo, Hope S.
Julkaisussa J Clin Oncol (2020)

Using diagnosis codes in claims data to identify cohorts of breast cancer patients following initial treatment

Tekijä Franc, Benjamin L., Thombley, Robert, Luo, Yanting, Boscardin, John, Rugo, Hope S., Seidenwurm, David, Dudley, R. Adams
Julkaisussa Breast J (2020)

Response of Brain Metastases From PIK3CA-Mutant Breast Cancer to Alpelisib

Tekijä Batalini, Felipe, Moulder, Stacy L., Winer, Eric P., Rugo, Hope S., Lin, Nancy U., Wulf, Gerburg M.
Julkaisussa JCO Precis Oncol (2020)

Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis

Tekijä Belkora, Jeffrey K, Rugo, Hope S, Moore, Dan H, Hutton, David W, Chen, Daniel F, Esserman, Laura J
Julkaistu 2009